IP36-19: Lymphovascular invasion and nodal positivity as useful markers for selecting candidates for adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma

IP36-19: Lymphovascular invasion and nodal positivity as useful markers for selecting candidates for adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma

Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!